News
-
-
-
-
-
-
-
-
-
PRESS RELEASE
BioNxt Delivers Positive Results in Patented Cladribine Sublingual Thin-Film Program and Completes Successful Formulation
BioNxt Solutions Inc. announces successful development of sublingual thin-film prototype for cladribine-based drug delivery in multiple sclerosis treatment, strengthening clinical development path -
PRESS RELEASE
Point d'information sur la situation de Transition Evergreen et de sa société de gestion Aqua AM - Nouveau report de la publication des comptes annuels 2024
Transition Evergreen (EGR) annonce la liquidation judiciaire d'Aqua Asset Management et sa transformation en société holding. Point sur la conciliation et les comptes annuels 2024